AVEO Oncology
AVEO
#7143
Rank
C$0.71 B
Marketcap
C$20.46
Share price
0.00%
Change (1 day)
150.94%
Change (1 year)

Earnings for AVEO Oncology (AVEO)

Earnings in 2022 (TTM): -C$37.21 Million

According to AVEO Oncology 's latest financial reports the company's current earnings are C$94.31 Million. In 2021 the company made an earning of -C$72.76 Million a decrease over its 2020 earnings that were of -C$48.54 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AVEO Oncology from 2009 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) -C$37.21 Million-48.87%
2021 -C$72.76 Million49.9%
2020 -C$48.54 Million-479.04%
2019 C$12.8 M-276.17%
2018 -C$7.27 Million-91.79%
2017 -C$88.56 Million142.38%
2016 -C$36.54 Million78.51%
2015 -C$20.47 Million-71.55%
2014 -C$71.94 Million-50.72%
2013 -C$0.15 Billion-4.88%
2012 -C$0.16 Billion-426.29%
2011 C$47.03 M-159.85%
2010 -C$78.6 Million35.33%
2009 -C$58.08 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eli Lilly
LLY
C$30.69 B-77,594.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$11.24 B-28,489.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$2.59 B-6,656.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
C$7.01 B-17,817.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$10.95 B-27,762.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
-C$3.09 Million-92.22%๐Ÿ‡บ๐Ÿ‡ธ USA